pfizer inc.

Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low.

Pfizer CEO Albert Bourla criticized the "despicable" testimony of three elite university presidents who were "hiding behind calls for 'context'" before deeming such rhetoric impermissible.

Pfizer is shelving development of a twice-daily version of its weight loss drug after a trial proved users reported high rates of adverse side effects.

Texas Attorney General Ken Paxton has filed a lawsuit against Pfizer, alleging that the pharmaceutical giant lied about the effectiveness of its COVID-19 vaccine.

More than 100 CEOs and business leaders in New York City are calling for federal action to fix the United States' broken immigration system and address the migrant crisis.

News that the Biden administration is planning to push for Americans to get the updated COVID vaccines this fall caused several vaccine manufacturers' stock prices to rise Monday.

Conservatives on Twitter are calling out multinational corporations for displaying a pride flag-theamed logo on American social media accounts, but not for those overseas.

Poland has called on Pfizer to come to more favorable terms in negotiations to lower the total amount of COVID-19 doses it is sending.

University of San Diego finance professor Dan Roccato shared some market insights and investing tips for the New Year of 2023 on "Fox & Friends" on Monday.

The White House says it was not in any way involved in China's approval of Pfizer's COVID-19 pill to treat an anticipated wave of infections.